Sitemap

• Home
  • A to Z
  • Privacy
  • Terms and Conditions
  • Our Complaints Policy
• About Breakthrough
  • Research Strategy
  • Vacancies
  • Contact Us
  • C321) Higher Scientific Officer - Breakthrough Breast Cancer Research Centre
  • Scientific Officer - Breakthrough Toby Robins Breast Cancer Research Centre
• Breakthrough Research Centre
  • History & Funding
  • The Director
  • Research Teams
    • Apoptosis
      • Team Leader
      • The Team
      • Publications
      • Projects
        • IAPs as Ub-receptors in Ub-dependent survival signalling
        • Ub-mediated regulation of caspases
        • Linking microbial infections to chronic inflammation and cancer.
        • Ubiquitin-mediated regulation of apoptosis
        • Systematic analysis of putative components of the Drosophila cell death machinery and innate immune response
        • Overcoming the anti-apoptotic threshold
    • Breast Development
      • The Group
      • Publications
      • Projects
        • Migration of primitive mammary cells
    • Cancer Informatics
      • The Team
      • Team Leader
      • Publications
      • Projects
    • Drug Target Discovery
      • The Team
      • Team Leader
      • Publications
      • Projects
        • Investigation of Mps1 involvement in the mitotic checkpoint
    • Genetic Epidemiology
      • Publications
      • The Group
      • Projects
    • Gene Function
      • The Team
      • Team Leader
      • Gene Function and Regulation Subteam
        • Projects
        • The Team
        • Publications
    • Mammary Stem Cells
      • The Team
      • Team Leader
      • Publications
      • Projects
        • Characterisation of stem cell populations in tumour models and understanding the cells of origin of different breast cancer types
    • Molecular Cell Biology
      • The Team
      • Team Leader
      • Publications
      • Projects
        • Stromal fibroblasts in breast cancer invasion
        • The pericyte receptor endosialin in tumour angiogenesis
        • Recruitment and activation of mesenchymal stem cells in tumour progression and metastasis
        • Tumour and metastasis suppressor genes
        • Myoepithelial differentiation in basal-like breast tumours
        • Functional and therapeutic implications of the receptor tyrosine kinase RET in breast cancer
        • An intraductal approach to the identification of breast cancer biomarkers
    • Molecular Endocrinology
      • The Team
      • Team Leader
      • Publications
      • Projects
    • Molecular Pathology
      • The Team
      • Team Leader
      • Publications
      • Projects
        • HER2 positive breast cancer
    • Translational Research
      • The Team
      • Team Leader
      • Publications
      • Projects
    • Tumour Angiogenesis Group
      • Publications
      • Group Leader
      • The Group
      • Projects
        • Understanding dose-response relationships in angiogenesis
        • The role of VEGFR2 trafficking and signalling in angiogenesis
        • Role of the tumour microenvironment in resistance to angiogenesis inhibitors
        • Identification of genes that modify sensitivity to angiogenesis inhibitors
  • Scientific Support
    • Microarray Facility
      • Team Members
    • Histopathology Facility
  • Contact Us
• Research Units & Programmes
  • Edinburgh
    • Unit Director
    • Research Teams
      • Nuclear Organisation and Gene Expression
        • Team Members
        • Team Leader
        • Publications
        • Projects
          • Chromatin Organisation in the nucleus of cancer cells
      • Edinburgh Breast Cancer Research Group
        • Edinburgh Breast Cancer Research Group Team
        • Team Leader - Professor Mike Dixon
        • Publications Mechanisms of Endocrine Resistance
        • Projects
          • Gene expression signature to predict neo-adjuvant response to Letrozole
      • Endocrine Cancer Group
        • Team Leader
        • Publications
        • The Team
        • Projects
          • Association of coactivators and corepressors with endocrine resistance
          • Molecular profiling of clinically tamoxifen resistant cancers.
          • Receptor tyrosine kinases as predictive biomarkers of tamoxifen resistance in early breast cancer
      • Genome Stability
        • Team Leader
        • The Team
        • Publications
        • Projects
          • Chromatin Fibre Structure: Providing the Right Environment for Transcription
          • Polycomb Complexes – The Cell’s Transcriptional Rheostat
      • Applied Bioinformatics of Cancer
        • Publications
        • Team Leader
        • The Team
        • Projects
          • Characterizing response to treatment and predicting who will best respond
          • Dataset bias and meta-analysis
          • Models of breast cancer and resistance
          • Risk factors and prevention strategies
      • DNA methyltransferase in Breast Cancer.
        • Team Leader
        • Team members
        • Publications
        • Projects
          • DNA methyltransferase projects
      • Systems Pathology Group
        • David Harrison's research team
        • Team Leader David Harrison
        • Publications
      • Breast Pathology
        • Dr Jeremy Thomas
        • Publications - Breast Pathology
    • Contact Us
  • Manchester
    • Research Teams
      • Göran Landberg
  • King's College London
  • Barry Gusterson
    • Team Leader
      • Team Leader
    • Projects
      • Annexin A8 in mammary gland development and breast cancer
      • The role of the Reelin pathway in mammary gland development and breast cancer
      • The Role of RNA Interference In Epigenetic Silencing In Breast Cancer
    • The Team
    • Publications
• Breakthrough Generations & Population Studies
  • Breakthrough Generations Study
    • Laboratory
    • The Team
  • Male Breast Cancer Study
  • Hodgkin's Disease Study
  • BCCOM
• Clinical Trials & Clinical Researchers
  • Clinical Trials
    • BRCA Trial
      • Health Professionals
      • Patients and General Public
    • PARP Inhibitor Trial
    • Triple Negative Trial
    • ACU.FATIGUE Trial
  • Clinical Researchers
    • Breakthrough Clinician Scientist - Anthony Kong
    • Avon Fellows
      • Hartmut Kristeleit
      • Susana Banerjee
      • Kai-Keen Shiu
      • Juanita Lopez
• Research Funding
  • Decision Making And Monitoring
    • Best Practice In Research Funding
    • Our Funding Decision Process
      • Shortlisting and peer review
      • Selection criteria and decision-making
    • Monitoring Our Research
      • Monitoring our programme grants
      • Monitoring Breakthrough's clinical researchers
      • Monitoring Breakthrough's clinical trials
    • Measuring The Returns
    • Scientific Advisory Committee
  • Funding Available
    • Programme Grants
    • Personal Awards
      • Avon Clinical Research Training Fellowships
      • Breakthrough Clinical Researcher Programme
        • Breakthrough Clinician Scientist Fellowship
        • Breakthrough Senior Clinical Academic Fellowship
        • Breakthrough Clinical Researcher Committee
    • Project Grants
      • Intramural Project Grants
      • Breakthrough Intramural Research Committee
      • Complementary Therapy Research Programme
      • Complementary therapies
  • Guidance For Our Researchers
• News & events
  • Breakthrough Breast Cancer audit reveals striking differences in breast cancer treatment based on age
  • Breakthrough Breast Cancer scientists develop new method to predict patient response to Herceptin
  • New Drug Targeting Cancer Weakness Shows Great Promise
  • Scientists open the door to future 2-in-1 breast cancer treatments
  • Women take extreme diet to help Breakthrough Breast Cancer scientists make important discovery about weight and breast cancer risk